Indications and uses
Helps prevent sunburn
LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2013-12-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:38:34
Label at a glance#
ProductLBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (CLAIRE 1) - BEIGE
Active ingredientZinc Oxide
Label structure18 sections
Dosage and administration
Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor Apply to the forehead, nose, chin and both cheeks. Blend with Circular motion and spread softly without stretching the skin
Storage and handling
Protect the product in this container from excessive heat and direct sun.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredients
Zinc oxide 1.6%
Purpose
Sunscreen
Uses
- Helps prevent sunburn
Warnings
SPL UNCLASSIFIED SECTION
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
SPL UNCLASSIFIED SECTION
- For external use only
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 hours
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor
- Apply to the forehead, nose, chin and both cheeks. Blend with Circular motion and spread softly without stretching the skin
Other information
- Protect the product in this container from excessive heat and direct sun.
Inactive ingredients
Water, cyclopentasiloxane, trimethylsiloxysilicate, dimethicone, polymethyl methacrylate, peg/ppg-18/18 dimethicone, cyclohexasiloxane, methyl methacrylate crosspolymer, sodium chloride, bis-hydroxyethoxypropyl dimethicone, bis-peg-18 methyl ether dimethyl silane, peg/ppg-19/19 dimethicone, glycerin, oleth-5, phenyl trimethicone, hydrolyzed soy protein, propylene glycol, silica silylate, mica, methylparaben, triethoxycaprylylsilane, propylparaben, tocopheryl acetate, phenoxyethanol, fragrance, butylparaben, ethylparaben, silica, isobutylparaben.
May contain:
Titanium dioxide, iron oxides, iron oxides, iron oxides, bismuth oxychloride.
SPL UNCLASSIFIED SECTION
Distributed by Ventura Corporation, Ltd. San Juan, Puerto Rico 00926.
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Claire 1 - Beige
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Claire 2 - Beige
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Claire 3 - Beige
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Claire 4 - Beige
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Medium 5 - Brown
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Medium 6 - Brown
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Medium 7 - Brown
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Obscure 8 - Brown
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 ml Tube Carton - Obscure 9 - Brown
EFFET
PARFAIT
maximum comfort
and long-lasting
foundation
SPF 10
30 ml e (1 fl.oz.)
L'BEL
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| bis-peg-18 methyl ether dimethyl silane | INACTIVE INGREDIENT | OEB4R3WW9C | 1 | |
| bismuth oxychloride | INACTIVE INGREDIENT | 4ZR792I587 | 1 | |
| butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| isobutylparaben | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| oleth-5 | INACTIVE INGREDIENT | 1GH33785AY | 1 | |
| peg/ppg-18/18 dimethicone | INACTIVE INGREDIENT | 9H0AO7T794 | 1 | |
| peg/ppg-19/19 dimethicone | INACTIVE INGREDIENT | EHH90CO7TL | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| phenyl trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (CLAIRE 1) - BEIGE
- Zinc Oxide
- water
- cyclomethicone 5
- dimethicone
- peg/ppg-18/18 dimethicone
- cyclomethicone 6
- sodium chloride
- bis-peg-18 methyl ether dimethyl silane
- peg/ppg-19/19 dimethicone
- glycerin
- oleth-5
- phenyl trimethicone
- propylene glycol
- mica
- methylparaben
- triethoxycaprylylsilane
- propylparaben
- .alpha.-tocopherol acetate
- phenoxyethanol
- butylparaben
- ethylparaben
- silicon dioxide
- isobutylparaben
- titanium dioxide
- ferric oxide red
- bismuth oxychloride
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (CLAIRE 2) - BEIGE
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (CLAIRE 3)- BEIGE
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (CLAIRE 4) - BEIGE
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (MEDIUM 5) - BROWN
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (MEDIUM 6) - BROWN
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (MEDIUM 7) - BROWN
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (OBSCURE 8) - BROWN
- LBEL MAXIMUM COMFORT AND LONG-LASTING FOUNDATION SPF 10 (OBSCURE 9) - BROWN
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | IMPLANT / SUBCUTANEOUS | 77 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RECTAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / EPIDURAL | 648 mg | ||
| butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | CREAM / TOPICAL | 0.4 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE / ORAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRALESIONAL | 0.9 %w/v | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, EXTENDED RELEASE / ORAL | 0.12 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 338bba81-29ab-cbc0-e063-6394a90afe36 | 851a84db-2eeb-4e86-924f-1c152182eb33 | 2025-04-24 | Warnings | 851a84db-2eeb-4e86-924f-1c152182eb33 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.